Evidence for presence of a reduced form of digoxin-like immunoreactive factor (dihydro-DLIF) in mammalian tissues

Clinical Chemistry

Volumn 42, Issue 7, 1996, Pages 1092-1099

  Qazzaz, Hassan M A M ^a   Jortani, Saeed A ^a   Poole, James M ^a   Valdes Jr , Roland ^a,b  

^a University of Louisville School of Medicine   (United States)

^b Department of Pathology ^*  (United States)

Author keywords

cardiac glycoside; congeners; cytochrome P 450; digitalis; immunoassay; microsomal metabolism; sodium pump

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CARDIAC GLYCOSIDE; CYTOCHROME P450; DIGITALIS; DIGITALIS LIKE FACTOR; DIGOXIGENIN; DIGOXIN; DIHYDRODIGOXIN;

ADRENAL GLAND; ANIMAL TISSUE; ARTICLE; BIOTRANSFORMATION; CATTLE; CROSS REACTION; DIGITALIS INTOXICATION; HEART DISEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTENSION; ION CONDUCTANCE; KIDNEY FAILURE; LIVER FAILURE; MICROSOME; NONHUMAN; PREGNANCY; ULTRAVIOLET SPECTROPHOTOMETRY;

ANIMALIA; BOS TAURUS; BOVINAE; DIGITALIS; MAMMALIA;

EID: 0029987682     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/42.7.1092     Document Type: Article

References (38)

1. Drugs dispensed most often in U.S. community pharmacies. Am Druggist 1995;February:21-2.
2. Gruber KA, Whitacker JM, Buckalew VM Jr. Endogenous digitalis-like substance in plasma of volume expanded dogs. Nature 1980;287:743-9.
3. Valdes R Jr. Endogenous digoxin-like immunoreactive factors: impact on digoxin measurements and potential physiological implications [Review]. Clin Chem 1985;31:1525-32.
4. Shaikh IM, Lau BWC, Siegfried BA, Valdes R Jr. Isolation of digoxin-like immunoreactive factors from mammalian adrenal cortex. J Biol Chem 1991;266:13672-8.
5. Ludens JH, Clark MA, DuChrame DW, Harris DW, Lutzke BS, Mandel F, et al. Purification of an endogenous digitalis-like factor from human plasma for structural analysis. Hypertension 1991; 17:923-9.
6. 2+ stores and cell responsiveness. Am J Physiol 1993;264:1367-87.
7. Rose AM, Valdes R Jr. Understanding the sodium pump and its relevance to disease [Review]. Clin Chem 1994;40:1674-85.
8. Gault HM, Gallway B, Fine A, Vasdev S. Rising serum digoxin without further dosage in acute renal failure. Nephron 1984;37: 190-4.
9. Graves SW, Brown BA, Valdes R Jr. An endogenous digoxin-like substance in patients with renal impairment. Ann Intern Med 1983;99:604-8.
10. Nanji AA, Greenway DC. Correlation between serum albumin and digoxin-like immunoreactive substance in liver disease. J Clin Pharmacol 1986;26:152-3.
11. Graves SW, Valdes R Jr, Brown BA, Knight AB, Craig HR. Endogenous digoxin-immunoreactive substance in human pregnancies. J Clin Endocrinol Metab 1984;58:748-51.
12. Valdes R Jr, Graves SW, Brown BA, Landt ML. Endogenous substance in newborn infants causing false positive digoxin measurements, J Pediatr 1983;102:947-50.
13. Seccombe DW, Pudek MR, Whitfield MF, Jacobson BE, Wittmann BK, King JF. Perinatal changes in a digoxin-like immunoreactive substance. Pediatr Res 1984;18:1097-9.
14. Valdes R Jr, Graves SW, Knight AB, Graig HR. Endogenous digoxin immunoactivity is elevated in hypertensive pregnancy. Prog Clin Biol Res 1985;192:229-32.
15. Delva P, Capra C, Degan M, Minuz P, Covi G, Milan L. High plasma levels of ouabain-like factor in normal pregnancy and in pre-eclampsia. Eur J Clin Invest 1989;19:95-100.
16. Haddy FJ. Endogenous digoxin-like factors. ISI Atlas Sci Pharmacol 1987;1:119-23.
17. Graves SW, Lincoln K, Cook SL, Seely EW. Digitalis-like factor and digoxin immunoreactive factor in diabetic women with pre-eclampsia, transient hypertension of pregnancy, and normotensive pregnancy. Am J Hypertens 1995;8:5-11.
18. Qazzaz HMA, Goudy SL, Miller JJ, Valdes R Jr. Treatment of human serum with sulfosalicylic acid structurally alters digoxin and endogenous digoxin-like immunoreactive factor. Ther Drug Monit 1995;17:53-9.
19. Thomas R, Gray P, Andrews J. Digitalis: its mode of action, receptor, and structure-activity relationships. Adv Drug Res 1990; 19:313-545.
20. Qazzaz HMA, Goudy SL, Valdes R Jr. Deglycosylated products of endogenous digoxin-like immunoreactive factor (DLIF) in mammalian tissue. J Biol Chem 1996;271:8731-7.
21. Qazzaz HMA, Goudy SL, Valdes R Jr. Deglycosylated congeners produced from parent endogenous digoxin immunoreactive factors (DLIF) by acid hydrolysis [Abstract]. FASEB J 1994;8:A1415.
22. Qazzaz HMA, Valdes R Jr. Simultaneous isolation of endogenous digoxin-like immunoreactive factor (DLIF), ouabain-like factor (OLF), and deglycosylated congeners from mammalian tissues. Arch Biochem Biophys 1996;328:193-200.
23. Desta B. Separation of digoxin from dihydrodigoxin and the other metabolites by high-performance liquid chromatography with post-column derivatization. J Chromatogr 1987;421:381-6.
24. Valdes R Jr, Graves SW. Protein binding of endogenous digoxin-immunoactive factors in human serum and its variation with clinical condition. J Clin Endocrinol Metab 1985;60:1135-43.
25. Butler VP Jr, Tse-Eng D, Lindenbaum J, Kaiman SM, Preibisz JJ, Rund DH, Wissel PS. The development and application of a radioimmunoassay for dihydrodigoxin, a digoxin metabolite. J Pharmacol Exp Ther 1982;45:20-36.
26. Dean WL. Isolation and reconstitution of Ca-pump from human and porcine platelets. Methods Enzymol 1988;157:351-60.
27. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
28. Phillips AH, Langdon RG. Hepatic triphosphopyridine nucleotide-cytochrome c reductase: isolation, characterization, and kinetic studies. J Biol Chem 1962;237:2652-60.
29. Bockbrader HN, Reuning RH. Spectral analysis of the configuration and solution conformation of dihydrodigoxigenin epimers. J Pharm Sci 1983;72:271-4.
30. Stone JA, Soldin SJ. Improved liquid chromatographic/immunoassay of digoxin in serum. Clin Chem 1988;34:2547-51.
31. Miller JJ, Straub RW, Valdes R Jr. Digoxin immunoassay with cross-reactivity of digoxin metabolites proportional to their biological activity. Clin Chem 1994;40:1898-903.
32. Greenwood H, Snedden W, Hayward RP, Landon J. The measurement of urinary digoxin and dihydrodigoxin by radioimmunoassay and mass spectroscopy. Clin Chim Acta 1975;62:213-24.
33. Delfert D, Valdes R Jr. Impact of digoxin-like immunoreactive factors on digoxin measurements by immunoassays. J Clin Immunoassay 1985;8:157-64.
34. Qazzaz HMA, Straub RW, Valdes R Jr. Homology of endogenous digoxin-like immunoreactive factor (DLIF) isolated from human serum and bovine adrenal cortex [Abstract]. Clin Chem 1995;41: S44.
35. Soldin SJ. Digoxin - issues and controversies [Review]. Clin Chem 1986;32:5-12.
36. Bockbrader HN, Reuning RH. Digoxin and metabolites in urine: a derivatization-high-performance liquid chromatographic method capable of quantitating individual epimers of dihydrodigoxin. J Chromatogr 1984;310:85-95.
37. Dobkin JF, Saha JR, Butler VP Jr, Neu HC, Lindenbaum J. Digoxin-inactivating bacteria identification in human gut flora. Science 1983;220:325-7.
38. Feng J, Lingrel JB. Analysis of amino acid residues in the H5-H6 transmembrane and extracellular domains of Na,K-ATPase α subunit identifies threonine 797 as a determinant of ouabain sensitivity. Biochemistry 1994;33:4218-24.